Shenzhen Xinhe Biomedical
1 clinical trials · Sponsor
◉ Watch Shenzhen Xinhe Biomedical
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors (NCT07594964) | Shenzhen Xinhe Biomedical | 2025-08-25 |
Track Shenzhen Xinhe Biomedical automatically
Every clearance here is in the API, with alerts when new ones post.